Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by investclubon Dec 23, 2019 7:00pm
257 Views
Post# 30485838

BNN Marketcall

BNN Marketcall
I have phoned in to BNN maybe a dozen times in the last 2 months no one seems willing to take my call so I sent off an email to them as follows  .... 

Theralase is a biopharma research company currently in phase 2 for Bladder cancer patients are stage 4 or higher. Once phase2 is well under way of the 100 patients in Canada & US they will initiate phase 1b in its 2nd indication perhaps brain or lung their treatment is photo dynamic. Theralase is confident it can become the new gold standard in cancer treatment with higher CR then current treatments. Is there anyone willing to give their opinion on this company  ..  I have called BNN and all say they don't cover this company which at this point of time I understand with limited data from phase 1 however won't 1 of your guest give an opinion or do all want to play safe till after TLT shoots it out of the ballpark?
Bullboard Posts